LEAH GILBERT: Open Payments
NPI 1184862641 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 21 payments from 10 companies in 2025. Trend: 2023 $357 · 2024 $259 · 2025 $613
Food & beverage: $562Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $215 |
| Intercept Pharmaceuticals, Inc. | 1 | $144 |
| Janssen Biotech, Inc. | 1 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Pharmacosmos Therapeutics Inc. | 1 | $39 |
| Madrigal Pharmaceuticals | 1 | $34 |
| Celltrion USA Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $14 |
Products named: OCALIVA, MAVYRET, TREMFYA, ENTYVIO, MONOFERRIC, REZDIFFRA, CREON, VIBERZI.
Industry payments across WA — which companies pay providers there.
